Janux Therapeutics
JANX
#3995
Rank
โ‚ฌ2.18 B
Marketcap
41,91ย โ‚ฌ
Share price
0.41%
Change (1 day)
340.13%
Change (1 year)

Revenue for Janux Therapeutics (JANX)

Revenue in 2024 (TTM): โ‚ฌ14.06 M

According to Janux Therapeutics's latest financial reports the company's current revenue (TTM) is โ‚ฌ13.65 M. In 2023 the company made a revenue of โ‚ฌ7.31 M a decrease over the revenue in the year 2022 that were of โ‚ฌ8.02 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Janux Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ14.06 M92.33%
2023 โ‚ฌ7.31 M-8.93%
2022 โ‚ฌ8.02 M151.14%
2021 โ‚ฌ3.19 M
2020 N/A